Sign up to get free evidence-based articles, exclusive discounts, and insights from industry-leaders.
Email could not be subscribed.
Thank you for signing up!
presented by Barbara DeMarco, PT, OT, PhD
Financial: Barbara Gladson receives compensation from MedBridge for this course. There is no financial interest beyond the production of this course.
Non-Financial: Barbara Gladson has no competing non-financial interests or relationships with regard to the content presented in this course.
Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.
MedBridge is committed to accessibility for all of our subscribers. If you are in need of a disability-related accommodation, please contact [email protected]. We will process requests for reasonable accommodation and will provide reasonable accommodations where appropriate, in a prompt and efficient manner.
This course summarizes the pathophysiology of cardiac disease with regard to its pharmacologic treatment. Students will learn about nitroglycerin and how to use the patient's response to differentiate angina from an MI. Students will also learn about drugs for high cholesterol and how to distinguish their side effects from true musculoskeletal impairments. The course will also cover drug treatment for congestive heart failure and explain the limitations of antiarrhythmic drugs.
Barbara DeMarco, PT, OT, PhD
Dr. DeMarco (formerly Gladson) is the Senior Associate Dean for Education at the Rutgers University School of Health Professions and is currently co-leading the Workforce Development Core for the New Jersey Alliance for Clinical and Translational Science's NIH CTSA for Princeton, New Jersey Institute of Technology and Rutgers Biomedical and Health Sciences. She also is…
Read full bio1. Angina
In chapter one, Barbara Gladson will define Angina, Mechanism of action of Nitroglycerin, and the administration of sublingual Nitro to reduce Angina.
2. Clot Prevention and Treatment
Chapter two will discuss the role of platelet aggregator inhibitors, anticoagulants, and thrombolytics in coronary heart disease and their implications for therapeutic interventions. Barbara Gladson will cover the controversial role of aspirin in preventing cardiac events and explain the dosing regimen for a patient who takes NSAIDs for arthritis and low-dose aspirin for cardio protection.
3. Lipid Control
Barbara Gladson will explain the role of statins in reducing high cholesterol and assess patient response to determine statin related problems in this chapter. She will also list agents used to improve organ perfusion in Congestive Heart Disease and
4. Heart Failure
In the final lecture chapter, Gladson will review heart failure and the stages of therapy. She will also cover cognitive function in association with heart failure and other conditions connected to it.
5. Question and Answer
A question and answer session with Barbara Gladson and PT Holly Tanner, in which they will discuss the topics cover in this course and how they relate to practice.
Email could not be subscribed.
Thank you for signing up!
Email could not be subscribed.
Thank you for signing up!
For groups of 5 or more, request a demo to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.
Contact sales to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.